Segment And Geographic Information

12 Months Ended

Dec. 31, 2011

Segment And Geographic Information [Abstract]

Segment And Geographic Information

18. Segment and Geographic Information

     The Company has two reportable segments organized according to its services and products: Preservation Services and Medical Devices. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues during 2011 and 2010 and from shipments of previously preserved orthopaedic tissues during 2009. The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, HemoStase, and revascularization technologies, as well as sales of other medical devices. There are no intersegment revenues.

     The primary measure of segment performance, as viewed by the Company's management, is segment gross margin, or net external revenues less cost of preservation services and products. The Company does not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. The following table summarizes revenues, cost of services and products, and gross margins for the Company's operating segments (in thousands):

		2011		2010		2009
Revenues:
Preservation services	$	59,793	$	59,724	$	56,456
Medical devices		59,387		56,370		54,162
Other a		446		551		1,067
Total revenues		119,626		116,645		111,685
Cost of preservation services and products:
Preservation services		34,340		35,868		32,767
Medical devices		9,442		12,409		9,150
Total cost of preservation services and products		43,782		48,277		41,917
Gross margin:
Preservation services		25,453		23,856		23,689
Medical devices		49,945		43,961		45,012
Other a		446		551		1,067
Total gross margin	$	75,844	$	68,368	$	69,768

Net revenues by product for the years ended December 31, 2011, 2010, and 2009 were as follows (in thousands):

		2011		2010			2009
Preservation services:
Cardiac tissue	$	26,618	$	27,997		$	26,074
Vascular tissue		33,175		31,727			30,201
Orthopaedic tissue		-		-			181
Total preservation services		59,793		59,724			56,456
Products:
BioGlue and BioFoam		49,455		47,383			47,906
PerClot		2,528		264			-
HemoStase		1,699		8,793			6,008
Revascularization technologies		5,705		-			-
Other medical devices		-		(70	)		248
Total products		59,387		56,370			54,162
Other a		446		551			1,067
Total revenues	$	119,626	$	116,645		$	111,685

a For the years ended December 31, 2011, 2010 and 2009 the "Other" designation includes grant revenue.

     Net revenues by geographic location attributed to countries based on the location of the customer for the years ended December 31, 2011, 2010, and 2009 were as follows (in thousands):

		2011		2010		2009
U.S.	$	95,975	$	97,037	$	94,094
International		23,651		19,608		17,591
Total	$	119,626	$	116,645	$	111,685

     At December 31, 2011 and 2010, over 95% of the long-lived assets of the Company were held in the U.S., where all Company manufacturing facilities and the corporate headquarters are located. At December 31, 2011 all of the Company's $4.2 million in goodwill was allocated to its Medical Devices segment.